BP002014-PRO-1020: Recombinant Human Tropomyosin-3 (TPM3) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP002572-PKA-039: Recombinant Human Mitogen-Activated Protein Kinase 9 (MAPK9)
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP002749-PKA-273: Recombinant Human Mitogen-Activated Protein Kinase 13 (MAPK13)
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP002363-PRO-495: Recombinant Human Microtubule-Associated Proteins 1A/1B Light Chain 3A (MAP1LC3A) Protein
Source: E. coli-derived.
Purity: > 95.0% by SDS-PAGE.BP002478-CYT-133: Recombinant Human Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF), His Tag Protein
Source: E. coli-derived.
Purity: > 90.0% as determined by RP-HPLC and SDS-PAGE.BP002478-CYT-141: Recombinant Human Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Protein
Source: E. coli-derived.
The ED50 was determined by its ability to stimulate the proliferation of rat C6 cells is typically 15-25 ?g/ml.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.BP002325-PRO-1070: Recombinant Human Melanoma Antigen Family A 5 (MAGEA5) Protein
Source: E. coli-derived.
Purity: > 85% as determined by SDS-PAGE.BP001769-PRO-934: Recombinant Human MAD2 Mitotic Arrest Deficient-Like 1 (MAD2L1) Protein
Source: Escherichia Coli-derived.
Purity: >95% by SDS-PAGE.BP002845-PRO-795: Recombinant Mycoplasma Pneumoniae P1-N2
Source: E. coli-derived.
Purity > 95% as determined by 12% PAGE (Coomassie staining).
Applications: lateral follow product, ELISA assay and vaccine development.BP002845-PRO-801: Recombinant Mycoplasma Pneumoniae P1-C
Source: E. coli-derived.
Purity > 95% as determined by 12% PAGE (Coomassie staining).
Applications: lateral follow product, ELISA assay and vaccine development.